• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
[Gln8]-Luteinizing Hormone Releasing Hormone, chicken

[Gln8]-Luteinizing Hormone Releasing Hormone, chicken

Product ID L8277
Cas No. 47922-48-5
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $63.00 In stock
2 mg $107.00 Please Inquire
5 mg $189.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Luteinizing hormone-releasing hormone (LHRH or Gonadotropin-releasing hormone [GnRH]) is an endogenous peptide hormone that binds the GnRH receptor, stimulating secretion of reproductive hormones (such as luteinizing hormone [LH ] and follicle-stimulating hormone [FSH]) from the pituitary gland. Analogs of GnRH are clinically used to treat hormone-dependent diseases such as prostate and breast cancer, hyperplasia, and endometriosis.

Product Info

Cas No.

47922-48-5

Purity

≥95%

Formula

C54H71N15O14

Formula Wt.

1154.28

IUPAC Name

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-5-amino-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

Synonym

LHRH, GnRH

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

L8277 MSDS PDF

Info Sheet

L8277 Info Sheet PDF

References

Limonta P, Manea M. Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies. Cancer Treat Rev. 2013 Oct;39(6):647-63. PMID: 23290320.

Millar RP, Newton CL. Current and future applications of GnRH, kisspeptin and neurokinin B analogues. Nat Rev Endocrinol. 2013 Aug;9(8):451-66. PMID: 23817290.

Wu HM, Wang HS, Huang HY, et al. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2. BMC Cancer. 2013 Jun 20;13:300. PMID: 23786715.

Burel D, Li JH, Do-Rego JL, et al. Gonadotropin-releasing hormone stimulates the biosynthesis of pregnenolone sulfate and dehydroepiandrosterone sulfate in the hypothalamus. Endocrinology. 2013 Jun;154(6):2114-28. PMID: 23554453.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S1969

    Sermorelin Acetate

    Synthetic peptide, GHRH analog; GHRH agonist.
    ≥95%
  • S7061

    SRPIN340

    SRPK1 inhibitor.
    ≥98%
  • A044178

    Abemaciclib mesylate

    CDK inhibitor.
    ≥98%
  • M4000

    MK-2206 Monohydrochloride

    Akt inhibitor.
    ≥99%
  • B8248

    Bumetanide

    Loop diuretic; NKCC symporter and KCC2 co-transpor...
    ≥98%
  • C8500

    CV-65

    1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhibit...
    ≥60%
  • B3209

    Bicalutamide

    AR antagonist.
    ≥98%
  • P2856

    Phorbol-12,13-dibutyrate

    PKC and PKD activator, carcinogen.
    ≥98%
  • P0146

    Palmitoyl-L-carnitine

    Long chain acylcarnitine involved in fatty acid me...
    ≥98%
  • S7871

    Stresscopin, human

    Peptide, urocortin III analog; CRFR2 agonist.
    ≥95%
  • P7359

    Psoralidin

    Phenol found in Psoralea coryfolia.
    ≥98%
  • A7204

    AS-605240

    p110δ PI3K inhibitor.
    ≥98%
  • G6802

    Granisetron Hydrochloride

    5-HT3 antagonist.
    ≥98%
  • D0011

    Dacarbazine

    DNA alkylator.
    ≥98%
  • R0245

    Raltitrexed

    Folate analog; thymidylate synthase inhibitor.
    ≥98%
  • P2510

    4-Phenylbutylisothiocyanate

    Synthetic ITC.
    ≥98%
  • B5728

    Bohemine

    Purine derivative; CDK inhibitor.
    ≥98%
  • A5276

    Angiotensin I, human

    Endogenous peptide, cleavage product of angiotensi...
    ≥98%
  • F8272

    Fusarenon X

    Trichothecene mycotoxin produced by Fusarium.
    ≥98%
  • S0032

    Saikosaponin B1

    Saponin found in Bupleurum, Heteromorpha, and Scro...
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only